Literature DB >> 22579234

Pulmonary manifestations of sarcoidosis.

Robert P Baughman1, Elyse E Lower, Kevin Gibson.   

Abstract

Sarcoidosis affects the lungs in more than 90% of cases. Symptoms include cough, dyspnea, and chest pain. The entire respiratory tract can be involved. The most common areas of involvement are the airways and interstitium. Airway disease can lead to airway obstruction while interstitial lung disease can lead to restrictive disease. Patients may have a mix of these areas of involvement. For the symptomatic patient, the identification of disease involvement can usually be determined by pulmonary function testing and chest imaging. The chest X-ray staging system has been widely used in sarcoidosis, high-resolution computer tomography (HRCT) can provide detailed information regarding lung involvement. Unfortunately the various patterns seen on HRCT have limited the ability to develop a simple scoring system. Special studies such as bronchoscopy can be useful for detecting large airway disease. Other chest manifestations include adenopathy, pulmonary hypertension, and pulmonary muscle weakness. Fibrotic lung disease can lead to bronchiectasis, which can become infected.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22579234     DOI: 10.1016/j.lpm.2012.03.019

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  13 in total

1.  [Bilateral parotid gland swelling caused by...?: when the diagnosis is written in the stars!].

Authors:  K Stürzebecher; K Mertz; F Büttner; E Ullmer
Journal:  Radiologe       Date:  2013-11       Impact factor: 0.635

2.  Benefits of Physical Training in Sarcoidosis.

Authors:  Bert Strookappe; Jeff Swigris; Jolanda De Vries; Marjon Elfferich; Ton Knevel; Marjolein Drent
Journal:  Lung       Date:  2015-08-19       Impact factor: 2.584

3.  BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.

Authors:  Miriana d'Alessandro; Alfonso Carleo; Paolo Cameli; Laura Bergantini; Anna Perrone; Lucia Vietri; Nicola Lanzarone; Cecilia Vagaggini; Piersante Sestini; Elena Bargagli
Journal:  Clin Exp Med       Date:  2020-01-22       Impact factor: 3.984

Review 4.  Sarcoidosis and Thyroid Autoimmunity.

Authors:  Piera Fazzi; Poupak Fallahi; Silvia Martina Ferrari
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-08       Impact factor: 5.555

5.  Sarcoidosis and Its Splenic Wonder: A Rare Case of Isolated Splenic Sarcoidosis.

Authors:  Khushali Jhaveri; Abhay Vakil; Salim R Surani
Journal:  Case Rep Med       Date:  2018-11-05

6.  Peritoneal sarcoidosis: A case report.

Authors:  Seung Wook Lee; Min Hee Lee; Ji Eun Lee; Seo Youn Choi; Boem Ha Yi; Jung Min Jung
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

7.  First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative.

Authors:  Nynke A Kampstra; Jan C Grutters; Frouke T van Beek; Daniel A Culver; Robert P Baughman; Elisabetta A Renzoni; Wim Wuyts; Vaslis Kouranos; Marlies S Wijsenbeek; Douwe H Biesma; Philip J van der Wees; Paul B van der Nat
Journal:  BMJ Open Respir Res       Date:  2019-02-18

8.  Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability.

Authors:  C M R Hendriks; L A Saketkoo; M D P Elfferich; J De Vries; P A H M Wijnen; M Drent
Journal:  Lung       Date:  2019-05-17       Impact factor: 2.584

9.  Abdominal Sarcoidosis Mimicking Peritoneal Carcinomatosis.

Authors:  Won Seok Roh; Seungho Lee; Ji Hyun Park; Jeonghyun Kang
Journal:  Ann Coloproctol       Date:  2018-04-30

10.  Clinical phenotyping in sarcoidosis management.

Authors:  Giuseppe Domenico Rana; Miriana d'Alessandro; Luigi Rizzi; Laura Bergantini; Paolo Cameli; Alfredo Vozza; Piersante Sestini; Patrizia Suppressa; Elena Bargagli
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-06-28       Impact factor: 0.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.